USANA Q2 Sales Down 15.1%


USANA Health Sciences, Inc. (NYSE: USNA) second quarter 2019 net sales were $256.0 million, compared with $301.5 million in the prior-year period, or a 15.1 percent decrease year-over-year.

According to the company, its financial performance for the quarter was impacted by the continuing challenging consumer environment in China. In addition, the strengthening of the U.S. dollar unfavorably impacted net sales by $12.4 million for the quarter.

“The continuing challenging market environment in China was the major factor that impacted our second quarter results,” said Kevin Guest, chief executive officer. “We believe it could take several months for consumer sentiment and our momentum to improve in China. We remain optimistic in our long-term growth potential in this important market and our other markets around the world.”

Net sales in the Asia Pacific region decreased by 14.9 percent to $205.5 million for the second quarter of 2019. The total number of active customers in the Asia Pacific region decreased by 5.7 percent year-over-year. Active customers decreased by 12.3 percent in Greater China. In Southeast Asia Pacific and North Asia, Active customers increased by 2.9 percent and 27.0 percent, respectively.

Net sales in the Americas and Europe region decreased by 15.6 percent to $50.5 million for the second quarter of 2019, primarily due to an 11.6 percent decrease in active customers.

The company’s total number of active customers at the end of the second quarter was 555,000, compared to 597,000 in the prior-year period.

To read the full USANA Q2 report, click here.